ResMed Inc (RMD)

Current ratio

Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Total current assets US$ in thousands 3,208,420 2,836,180 2,641,120 2,357,720 2,351,300 2,378,080 2,304,580 2,367,830 2,337,820 2,325,160 2,033,700 1,931,480 1,704,300 1,547,240 1,586,260 1,574,760 1,466,150 1,451,480 1,542,610 1,523,460
Total current liabilities US$ in thousands 940,516 851,960 904,079 910,655 773,030 764,073 770,802 758,533 761,691 732,714 692,659 689,299 667,265 621,064 624,158 911,766 876,541 577,335 590,853 602,761
Current ratio 3.41 3.33 2.92 2.59 3.04 3.11 2.99 3.12 3.07 3.17 2.94 2.80 2.55 2.49 2.54 1.73 1.67 2.51 2.61 2.53

March 31, 2025 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $3,208,420K ÷ $940,516K
= 3.41

The current ratio of ResMed Inc. demonstrates a generally stable liquidity position over the period analyzed. Starting from a high of 2.53 on June 30, 2020, the ratio experienced a slight fluctuation, peaking at 2.94 on September 30, 2022, and reaching a high of 3.33 on December 31, 2024. Notably, there was a marked decrease around March 31, 2021, when the ratio declined to 1.67, which indicates a temporary reduction in liquidity, possibly due to increased short-term obligations or strategic inventory investments. Subsequently, from June 30, 2021, onward, the ratio recovered and maintained values consistently above 2.5, reflecting a sound short-term liquidity position.

Throughout the period from 2022 onwards, the current ratio showed an upward trend, attaining its peak during December 2024. Such elevated ratios suggest that ResMed holds a comfortable level of current assets relative to current liabilities, providing a safety margin to meet short-term obligations. Despite minor fluctuations, the current ratio remained within a range that indicates prudent liquidity management. The recent figures as of March 31, 2025, stand at 3.41, reaffirming the company's strong liquidity position.

This pattern indicates ResMed's emphasis on maintaining liquidity reserves well above the minimal critical threshold, signifying financial stability and capacity to manage upcoming short-term liabilities effectively. The overall trend underscores resilience and prudent liquidity management, with no indications of liquidity concerns during the analyzed period.